F Viazzi
Overview
Explore the profile of F Viazzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russo G, Giandalia A, Ceriello A, Di Bartolo P, Di Cianni G, Fioretto P, et al.
Diabetes Res Clin Pract
. 2022 Sep;
192:110092.
PMID: 36167264
Objective: To develop and validate a model for predicting 5-year eGFR-loss in type 2 diabetes mellitus (T2DM) patients with preserved renal function at baseline. Research Design And Methods: A cohort...
2.
Parodi E, La Porta E, Russo R, Marsano L, Bellino D, Paoletti E, et al.
Transplant Proc
. 2020 Jul;
52(10):3112-3117.
PMID: 32680595
Tacrolimus is a cornerstone in the immunosuppressive therapy of kidney transplantation. The once-daily formulation of tacrolimus has been shown to improve adherence of patients without affecting short-term efficacy. However, long-term...
3.
Maloberti A, Giannattasio C, Bombelli M, Desideri G, Cicero A, Muiesan M, et al.
High Blood Press Cardiovasc Prev
. 2020 Mar;
27(2):121-128.
PMID: 32157643
The latest European Guidelines of Arterial Hypertension have officially introduced uric acid evaluation among the cardiovascular risk factors that should be evaluated in order to stratify patient's risk. In fact,...
4.
Ratto E, Viazzi F, Verzola D, Bonino B, Gonnella A, Parodi E, et al.
J Hum Hypertens
. 2015 Jun;
30(3):158-63.
PMID: 26108365
Metabolic syndrome (MS) has been shown to predict cardiovascular events in hypertension. Recently, a new four-group left ventricular (LV) hypertrophy classification based on both LV dilatation and concentricity was proposed....
5.
Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan M, Ambrosioni E, et al.
Nutr Metab Cardiovasc Dis
. 2014 Mar;
24(8):921-7.
PMID: 24675005
Background And Aims: The independent role of serum uric acid (SUA) as a marker of cardio-renal risk is debated. The aim of this study was to assess the relationship between...
6.
Carbone F, Montecucco F, Mach F, Pontremoli R, Viazzi F
Thromb Haemost
. 2013 Aug;
110(5):940-58.
PMID: 23966104
The increased atherothrombotic risk in patients with metabolic syndrome (MetS) has been classically explained by the multiplicative effect of systemic concomitant pro-atherosclerotic factors. In particular, centripetal obesity, dyslipidaemia, glucose intolerance,...
7.
Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R
J Hum Hypertens
. 2013 Jun;
27(11):663-70.
PMID: 23739158
Organ damage (OD) is an indicator of increased cardiovascular risk. Blood pressure variability (BPV) is related to greater incidence of events, regardless of the severity of hypertension. We investigated the...
8.
Viazzi F, Leoncini G, Derchi L, Baratto E, Storace G, Vercelli M, et al.
J Hum Hypertens
. 2012 Feb;
27(2):95-9.
PMID: 22336904
Recent studies suggest a close relationship between renal dysfunction and new onset diabetes (NOD). The aim of the study was to investigate the association between subclinical functional and structural renal...
9.
Viazzi F, Leoncini G, Pontremoli R
Reumatismo
. 2012 Feb;
63(4):253-62.
PMID: 22303532
A number of epidemiological studies have reported an association between serum uric acid levels and a wide variety of high-risk conditions including hypertension, insulin resistance, and kidney and cerebro-cardiovascular disease....
10.
Leoncini G, Viazzi F, Vercelli M, Deferrari G, Pontremoli R
J Hum Hypertens
. 2011 Feb;
26(3):149-56.
PMID: 21289647
Metabolic syndrome (MS) has recently been shown to be a forerunner of chronic kidney disease (CKD). Microalbuminuria (MA) is associated with both MS and CKD. This study aimed to prospectively...